Skip to main content
. 2021 Mar 8;14(3):238. doi: 10.3390/ph14030238

Figure 2.

Figure 2

The AAPs-induced metabolic syndrome (MetS) is the consequence of a broad activity of these drugs on the central nervous system (CNS) and peripheral organs. In the CNS, the most important target is the hypothalamus, while in the periphery, the liver, pancreatic β-cells, adipose tissue and skeletal muscle are implicated in AAPs-induced MetS. By interfering with the activity of different GPCRs expressed in these regions, AAPs significantly alter glucose and lipid homeostasis.